Protagonist Therapeutics (PTGX) Earnings Date & Reports

Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

PTGX is expected to report earnings to rise 4.80% to $2.40 per share on November 05

Protagonist Therapeutics PTGX Stock Earnings Reports

Q3'26

Est.

$2.40

Q2'26

Beat

by $0.16

Q1'26

Beat

by $0.54

Q4'25

Missed

by $0.35

Q3'25

Beat

by $0.01

The last earnings report on August 05 showed earnings per share of $2.29, beating the estimate of $2.13. With 267.94K shares outstanding, the current market capitalization sits at 9.22B.

View a ticker or compare two or three

PTGX

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for PTGX